St. Mary's Hospital is a hospital located in Montreal, Quebec, Canada. Affiliated with McGill University, St. Mary's is an independent teaching hospital. The hospital is located at 3830 Lacombe Avenue in the borough of Côte-des-Neiges–Notre-Dame-de-Grâce.

There are 271 beds in St. Mary's Hospital Center.

During the past decade, St. Mary's Hospital Center conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 15 clinical trials were completed, i.e. on average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Mary's Hospital Center" #1 sponsor was "NSABP Foundation Inc" with 8 trials, followed by "Ottawa Hospital Research Institute" with 7 trials sponsored, "Sir Mortimer B. Davis - Jewish General Hospital" with 5 trials sponsored, "St. Mary's Research Center, Canada" with 5 trials sponsored and "McGill University" with 5 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Mary's Hospital Center" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 12 trials as a collaborator, "National Cancer Institute (NCI)" with 10 trials as a collaborator, "McGill University" with 4 trials as a collaborator, "Heart and Stroke Foundation of Canada" with 3 trials as a collaborator and "Sigvaris Corporation" with 3 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "St. Mary's Hospital Center" are "Breast Cancer" (10 trials), "Anxiety" (3 trials), "Deep Vein Thrombosis" (3 trials), "Venous Thromboembolism" (3 trials) and "Cancer" (2 trials). Many other conditions were trialed in "St. Mary's Hospital Center" in a lesser frequency.

Most popular intervention types in "St. Mary's Hospital Center" are "Drug" (28 trials), "Other" (11 trials), "Behavioral" (5 trials), "Procedure" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Placebo" (5 trials), "Docetaxel" (4 trials), "cyclophosphamide" (4 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. Mary's Hospital Center" are 33 trials for "All" genders, 21 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "St. Mary's Hospital Center". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 36 completed trials in St. Mary's Hospital Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in St. Mary's Hospital Center, 3 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 15 trials that are defined as “Not Applicable".